Pharmaceutical Firm Takes 85k SF At 55 Hudson Yards

Rendering of 55 Hudson Yards, a supertall office building on Manhattan's Far West Side
A Rendering Of 55 Hudson Yards

Only a day after money manager BlackRock agreed to take 850k SF in 50 Hudson Yards, Related Cos and Oxford Properties Group landed another tenant for its West Side megaproject.

Intercept Pharmaceuticals has signed an 85k SF lease for the 23rd through 25th floors of 55 Hudson Yards (pictured), making it the fifth firm to take space at the 51-story, 1.3M SF tower, after Boies, Schiller & Flexner, Point72, MarketAxxess and Milbank, The Real Deal reports.

The $2.6B pharma firm, currently in the Meatpacking District, also signed a 49k SF lease for the 40th floor of the 1.7M SF 10 Hudson Yards—the only completed building in Hudson Yards—where it will continue its research on liver disease while 55 Hudson Yards is constructed.

Newmark Grubb Knight Frank’s Paul Ippolito, Ira Rovitz and Seth Weinstein repped Intercept, while Related’s Stephen Winter repped the landlord in-house alongside CBRE’s Robert Alexander, Howard Fiddle and Emily Jones. [TRD]

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's New York Newsletters
Related Stories

The Blue Wave Has Foreign Capital Dipping Its Toes Back Into U.S. Commercial Real Estate

London's Largest All-Timber Office Development Takes Shape

Moinian Group Returns To Israeli Bondholders For Capital In NYC, Miami

191 Peachtree Loan Moves To Special Servicing After Banyan Misses Maturity

GPE Completes £369M City Sale: The London Deal Sheet

ERock Moving HQ With 72K SF Lease At Central Park Post Oak

UBS Signs First Lease At Stonelake Capital's Spec Office Tower In Uptown Dallas

Office REIT Sells Reston Property To Local Firm For 30% Of 2014 Price

Voya Financial Relocating Atlanta Office From 40-Year Home

Mamdani Admin Sues Bronx Landlords, Claiming Unpaid Fines Amount To Fraud

Congress Puts Up $216M For Energy Department Relocation From Forrestal

Sherwood Equities Sells Hudson Yards Development Site For $100M: The N.Y. Deal Sheet